[Prospects for cancer immunotherapy using interleukin-1(IL-1) and interleukin-2(IL-2)].
作者信息
Okuno K
出版信息
Nihon Rinsho. 1983;41(4):868-74.
PMID:6350655
Abstract
摘要
相似文献
1
[Prospects for cancer immunotherapy using interleukin-1(IL-1) and interleukin-2(IL-2)].使用白细胞介素-1（IL-1）和白细胞介素-2（IL-2）进行癌症免疫治疗的前景
Nihon Rinsho. 1983;41(4):868-74.
2
[Interleukin 1 in host anti-tumor mechanisms].[白细胞介素1在宿主抗肿瘤机制中的作用]
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):2105-10.
3
In vivo and in vitro activation of NK cytotoxicity with IL-2.利用白细胞介素-2在体内和体外激活自然杀伤细胞的细胞毒性。
Prog Clin Biol Res. 1987;244:275-85.
4
Immunotherapy of cancer using interleukin 2: current status and future prospects.使用白细胞介素-2进行癌症免疫治疗：现状与未来前景
Immunol Today. 1988 Feb;9(2):58-62. doi: 10.1016/0167-5699(88)91261-3.
5
Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.淋巴因子激活的杀伤细胞：癌症免疫治疗的新方法。
J Natl Cancer Inst. 1985 Oct;75(4):595-603.
6
Interleukin-2 and lymphokine activated killer cells: promises and cautions.
Ann Clin Lab Sci. 1989 Jan-Feb;19(1):51-5.
7
[Interleukin 2, killer cells and cancer].
Duodecim. 1988;104(9):685-9.
8
Adjuvant histamine in cancer immunotherapy.癌症免疫治疗中的佐剂组胺。
Semin Cancer Biol. 2000 Feb;10(1):29-39. doi: 10.1006/scbi.2000.0305.
9
10
Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells.宿主的局部条件会影响白细胞介素-2和LAK细胞的免疫治疗。
Cancer Detect Prev. 1988;12(1-6):81-90.
Zotero 插件